NPM1 and acute myeloid leukemia: Indeed, the parameters with an impact on CR, resulting from the logistic regression model, were younger age (OR 0.96 95% CI 0.94–0.98, p < 0.001), WHO performance status (OR 0.2 95% CI 0.07, 0.51, p = 0.001), de novo AML (OR 0.17, 95% CI 0.06–0.39, p < 0.001), NPM1 mutations (OR 2.26, 95% CI 1.29–4.42, p = 0.013), and conventional CHT treatment (OR 0.28, 95% CI 0.13–0.57, p < 0.001, Table S1).